| (-)-epigallocatechin 3-gallate | decreases expression | ISO | RGD:69473 | 6480464 | epigallocatechin gallate results in decreased expression of SREBF1 mRNA | CTD | PMID:20816778 |
| (2,4,5-trichlorophenoxy)acetic acid | increases expression | EXP | | 6480464 | 2,4,5-Trichlorophenoxyacetic Acid results in increased expression of SREBF1 mRNA | CTD | PMID:18579281 |
| (R)-carnitine | multiple interactions | ISO | RGD:69423 | 6480464 | Carnitine inhibits the reaction [Stavudine results in increased expression of SREBF1 mRNA] | CTD | PMID:18299183 |
| (S)-nicotine | decreases expression | ISO | RGD:69473 | 6480464 | Nicotine results in decreased expression of SREBF1 mRNA | CTD | PMID:18247414 |
| 1,10-phenanthroline | multiple interactions | ISO | RGD:69473 | 6480464 | [1,10-phenanthroline results in decreased activity of MBTPS2 protein] which affects the localization of SREBF1 protein; more ... | CTD | PMID:21355074 |
| 1-naphthyl isothiocyanate | decreases expression | ISO | RGD:69423 | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:69423 | 6480464 | Ethinyl Estradiol results in decreased expression of SREBF1 mRNA | CTD | PMID:17108234 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:69473 | 6480464 | Dihydrotestosterone results in increased expression of SREBF1 mRNA | CTD | PMID:16541421 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SREBF1 mRNA | CTD | PMID:20005886 PMID:21851831 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | decreases expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in decreased expression of SREBF1 mRNA | CTD | PMID:20005886 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA]; more ... | CTD | PMID:21851831 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69473 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69423 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:21215274 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:18295293 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69423 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:21215274 PMID:21724226 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | NFE2L2 gene mutant form inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of SREBF1 mRNA] | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA]; more ... | CTD | PMID:21851831 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:18295293 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SREBF1 mRNA | CTD | PMID:21846477 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:69423 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:20005886 PMID:18295293 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 protein | CTD | PMID:20181658 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA] | CTD | PMID:16054899 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SREBF1 mRNA | CTD | PMID:18295293 PMID:20005886 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:69423 | 6480464 | 2,4-dinitrotoluene affects the expression of SREBF1 mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:69423 | 6480464 | 2,6-dinitrotoluene affects the expression of SREBF1 mRNA | CTD | PMID:21346803 |
| 2-deoxy-D-glucose | increases expression | EXP | | 6480464 | Deoxyglucose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 |
| 2-naphthylamine | decreases expression | ISO | RGD:69473 | 6480464 | 2-Naphthylamine results in decreased expression of SREBF1 mRNA | CTD | PMID:18247414 |
| 25-hydroxycholesterol | increases expression | EXP | | 6480464 | 25-hydroxycholesterol results in increased expression of SREBF1 protein | CTD | PMID:19260826 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:16054899 |
| 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein; more ... | CTD | PMID:11101056 |
| 3H-1,2-dithiole-3-thione | increases expression | ISO | RGD:69423 | 6480464 | 1,2-dithiol-3-thione results in increased expression of SREBF1 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | decreases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in decreased expression of SREBF1 mRNA | CTD | PMID:18648102 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:69473 | 6480464 | [decitabine co-treated with Depsipeptides] results in increased expression of SREBF1 mRNA | CTD | PMID:17064661 |
| 8'-apo-beta,psi-caroten-8'-al | increases expression | ISO | RGD:69473 | 6480464 | apocarotenal results in increased expression of SREBF1 mRNA | CTD | PMID:17034753 |
| 8-bromo-3',5'-cyclic AMP | decreases expression | ISO | RGD:69473 | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of SREBF1 mRNA | CTD | PMID:22079614 |
| acetaldehyde | increases expression | ISO | RGD:69473 | 6480464 | Acetaldehyde results in increased expression of SREBF1 protein | CTD | PMID:12612910 |
| aflatoxin B1 | affects expression | ISO | RGD:69473 | 6480464 | Aflatoxin B1 affects the expression of SREBF1 protein | CTD | PMID:20106945 |
| aflatoxin B1 | decreases expression | ISO | RGD:69473 | 6480464 | Aflatoxin B1 results in decreased expression of SREBF1 mRNA | CTD | PMID:21641981 |
| aldehydo-D-glucosamine 6-phosphate | decreases expression | EXP | | 6480464 | glucosamine 6-phosphate results in decreased expression of SREBF1 protein | CTD | PMID:19427183 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | AGN 193109 inhibits the reaction [Tretinoin results in increased expression of SREBF1 mRNA] | CTD | PMID:16505366 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of SREBF1 mRNA | CTD | PMID:16505366 |
| alpha-linolenic acid | decreases expression | ISO | RGD:69423 | 6480464 | alpha-Linolenic Acid results in decreased expression of SREBF1 mRNA | CTD | PMID:14563831 |
| amiodarone | decreases expression | ISO | RGD:69423 | 6480464 | Amiodarone results in decreased expression of SREBF1 mRNA | CTD | PMID:17202758 |
| amitriptyline | multiple interactions | ISO | RGD:69473 | 6480464 | Amitriptyline results in increased cleavage of and results in increased activity of SREBF1 protein | CTD | PMID:16324787 |
| ammonium chloride | affects expression | ISO | RGD:69423 | 6480464 | Ammonium Chloride affects the expression of SREBF1 mRNA | CTD | PMID:16483693 |
| arsenic atom | multiple interactions | EXP | | 6480464 | [APOE protein affects the susceptibility to Arsenic] which results in increased expression of SREBF1 protein | CTD | PMID:22719926 |
| benzene | affects expression | ISO | RGD:69423 | 6480464 | Benzene affects the expression of SREBF1 mRNA | CTD | PMID:15878777 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:18247414 PMID:20106945 |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:18247414 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:21871943 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:20106945 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:69473 | 6480464 | Benzo(a)pyrene results in decreased expression of SREBF1 mRNA | CTD | PMID:20106945 PMID:18247414 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of SREBF1 mRNA | CTD | PMID:21715664 |
| berberine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:20564506 |
| beta-carotene | increases expression | ISO | RGD:69473 | 6480464 | beta Carotene results in increased expression of SREBF1 mRNA | CTD | PMID:17034753 |
| bezafibrate | multiple interactions | ISO | RGD:69473 | 6480464 | SREBF1 protein inhibits the reaction [cerivastatin promotes the reaction [Bezafibrate results in increased activity of [PPARA protein binds to RXRA protein]]] | CTD | PMID:11779144 |
| bezafibrate | increases expression | EXP | | 6480464 | Bezafibrate results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:19124612 |
| bezafibrate | multiple interactions | EXP | | 6480464 | [Bezafibrate results in decreased expression of SREBF1] which results in decreased abundance of Triglycerides; more ... | CTD | PMID:19124612 |
| bezafibrate | decreases expression | EXP | | 6480464 | Bezafibrate results in decreased expression of SREBF1 mRNA; more ... | CTD | PMID:19124612 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SREBF1 mRNA alternative form; more ... | CTD | PMID:21932408 |
| bisphenol A | increases expression | ISO | RGD:69423 | 6480464 | bisphenol A results in increased expression of SREBF1 mRNA | CTD | PMID:20019905 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of SREBF1 mRNA | CTD | PMID:21932408 |
| buta-1,3-diene | decreases expression | EXP | | 6480464 | 1,3-butadiene results in decreased expression of SREBF1 mRNA | CTD | PMID:21147608 |
| C60 fullerene | increases expression | ISO | RGD:69423 | 6480464 | fullerene C60 results in increased expression of SREBF1 mRNA | CTD | PMID:19167457 |
| calcitriol | decreases expression | EXP | | 6480464 | Calcitriol results in decreased expression of SREBF1 mRNA | CTD | PMID:16368784 |
| carvedilol | multiple interactions | ISO | RGD:69423 | 6480464 | carvedilol inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA] | CTD | PMID:22413959 |
| chenodeoxycholic acid | decreases expression | ISO | RGD:69473 | 6480464 | Chenodeoxycholic Acid results in decreased expression of SREBF1 mRNA | CTD | PMID:16269825 |
| chloroethene | increases expression | EXP | | 6480464 | Vinyl Chloride results in increased expression of SREBF1 mRNA | CTD | PMID:18579281 |
| choline | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:19593819 |
| ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of SREBF1 mRNA | CTD | PMID:18353800 |
| citalopram | multiple interactions | ISO | RGD:69473 | 6480464 | Citalopram results in increased cleavage of and results in increased activity of SREBF1 protein | CTD | PMID:16324787 |
| clofibrate | decreases expression | ISO | RGD:69423 | 6480464 | Clofibrate results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 |
| clofibrate | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SREBF1 mRNA; more ... | CTD | PMID:17585979 |
| clomipramine | multiple interactions | ISO | RGD:69473 | 6480464 | Clomipramine results in increased cleavage of and results in increased activity of SREBF1 protein | CTD | PMID:16324787 |
| clozapine | increases expression | ISO | RGD:69473 | 6480464 | Clozapine results in increased expression of SREBF1 mRNA | CTD | PMID:17052361 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of SREBF1 mRNA | CTD | PMID:19682446 PMID:20564506 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of SREBF1 protein | CTD | PMID:20564506 |
| clozapine | increases expression | EXP | | 6480464 | Clozapine results in increased expression of SREBF1 mRNA | CTD | PMID:20564506 PMID:19682446 |
| clozapine | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Clozapine results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:20564506 |
| cobalt dichloride | increases expression | ISO | RGD:69473 | 6480464 | cobaltous chloride results in increased expression of SREBF1 mRNA | CTD | PMID:19376846 |
| cobalt dichloride | increases expression | ISO | RGD:69473 | 6480464 | cobaltous chloride results in increased expression of SREBF1 mRNA | CTD | PMID:19376846 PMID:22917661 |
| cobalt dichloride | decreases expression | ISO | RGD:69473 | 6480464 | cobaltous chloride results in decreased expression of SREBF1 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:69473 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SREBF1 mRNA | CTD | PMID:20971185 |
| copper atom | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SREBF1 mRNA | CTD | PMID:17205981 |
| copper atom | affects localization | ISO | RGD:69423 | 6480464 | Copper deficiency affects the localization of SREBF1 protein | CTD | PMID:11110846 |
| copper(0) | multiple interactions | ISO | RGD:69473 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of SREBF1 mRNA | CTD | PMID:20971185 |
| copper(0) | affects localization | ISO | RGD:69423 | 6480464 | Copper deficiency affects the localization of SREBF1 protein | CTD | PMID:11110846 |
| copper(0) | decreases expression | EXP | | 6480464 | Copper results in decreased expression of SREBF1 mRNA | CTD | PMID:17205981 |
| corticosterone | multiple interactions | ISO | RGD:69423 | 6480464 | [Corticosterone co-treated with oleoyl-estrone] affects the expression of SREBF1 mRNA | CTD | PMID:19545626 |
| cyclosporin A | decreases expression | ISO | RGD:69473 | 6480464 | Cyclosporine results in decreased expression of SREBF1 mRNA | CTD | PMID:20106945 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 mRNA | CTD | PMID:15066988 PMID:10913129 |
| D-glucose | increases expression | ISO | RGD:69473 | 6480464 | Glucose results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:23319015 |
| D-glucose | multiple interactions | ISO | RGD:69473 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; more ... | CTD | PMID:23319015 |
| D-glucose | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein] | CTD | PMID:23090186 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 protein | CTD | PMID:23090186 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 PMID:15066988 |
| desmosterol | increases expression | EXP | | 6480464 | Desmosterol results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:19260826 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:16054899 |
| dexamethasone | multiple interactions | EXP | | 6480464 | [INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of SREBF1 protein; more ... | CTD | PMID:11101056 |
| diarsenic trioxide | decreases expression | ISO | RGD:69473 | 6480464 | arsenic trioxide results in decreased expression of SREBF1 mRNA | CTD | PMID:20458559 PMID:20339114 |
| diarsenic trioxide | decreases expression | ISO | RGD:69473 | 6480464 | arsenic trioxide results in decreased expression of SREBF1 mRNA | CTD | PMID:20339114 PMID:20458559 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of SREBF1 mRNA; more ... | CTD | PMID:20339114 |
| diarsenic trioxide | decreases expression | ISO | RGD:69473 | 6480464 | arsenic trioxide results in decreased expression of SREBF1 protein | CTD | PMID:20339114 |
| dibutyl phthalate | decreases expression | ISO | RGD:69423 | 6480464 | Dibutyl Phthalate results in decreased expression of SREBF1 mRNA | CTD | PMID:21266533 |
| diethyl maleate | decreases expression | ISO | RGD:69423 | 6480464 | diethyl maleate results in decreased expression of SREBF1 mRNA | CTD | PMID:21161181 |
| diethylstilbestrol | multiple interactions | EXP | | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of SREBF1 protein] | CTD | PMID:22710028 |
| diethylstilbestrol | increases expression | EXP | | 6480464 | Diethylstilbestrol results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:22710028 |
| elemental selenium | increases expression | ISO | RGD:69423 | 6480464 | Selenium results in increased expression of SREBF1 mRNA | CTD | PMID:19022953 |
| erythromycin estolate | decreases expression | ISO | RGD:69423 | 6480464 | Erythromycin Estolate results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 |
| ethanol | multiple interactions | EXP | | 6480464 | [Ethanol results in decreased activity of SIRT1 protein] which results in increased acetylation of and results in increased localization of and results in increased activity of SREBF1 protein | CTD | PMID:18239056 |
| ethanol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] | CTD | PMID:18755807 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 protein | CTD | PMID:18755807 more ... |
| ethanol | multiple interactions | ISO | RGD:69473 | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] | CTD | PMID:22138249 |
| ethanol | increases expression | ISO | RGD:69473 | 6480464 | Ethanol results in increased expression of SREBF1 protein | CTD | PMID:22138249 |
| ethanol | multiple interactions | EXP | | 6480464 | allyl sulfide inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] | CTD | PMID:22138249 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 protein | CTD | PMID:22138249 PMID:22459179 |
| ethanol | multiple interactions | EXP | | 6480464 | NFE2L2 protein affects the reaction [Ethanol results in increased expression of SREBF1 mRNA] | CTD | PMID:22627062 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:18620774 more ... |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 protein | CTD | PMID:22459179 |
| ethanol | increases expression | ISO | RGD:69423 | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:19371623 PMID:22413959 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:18620774 PMID:19167417 |
| ethanol | increases expression | ISO | RGD:69423 | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:22413959 PMID:19371623 |
| ethanol | multiple interactions | ISO | RGD:69423 | 6480464 | Ethanol promotes the reaction [SREBF1 protein binds to FAS promoter]; more ... | CTD | PMID:19371623 |
| ethanol | affects localization | ISO | RGD:69423 | 6480464 | Ethanol affects the localization of SREBF1 protein | CTD | PMID:19371623 |
| ethanol | increases expression | ISO | RGD:69423 | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:22413959 |
| ethanol | multiple interactions | ISO | RGD:69423 | 6480464 | carvedilol inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA] | CTD | PMID:22413959 |
| ethanol | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of SREBF1 mRNA] | CTD | PMID:22173916 |
| ethanol | decreases expression | EXP | | 6480464 | Ethanol results in decreased expression of SREBF1 mRNA | CTD | PMID:22173916 |
| ethanol | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA] | CTD | PMID:18620774 |
| ethanol | decreases expression | ISO | RGD:69423 | 6480464 | Ethanol results in decreased expression of SREBF1 mRNA | CTD | PMID:16098508 |
| ethanol | increases expression | EXP | | 6480464 | Ethanol results in increased expression of SREBF1 mRNA | CTD | PMID:18620774 |
| ethanol | increases activity | EXP | | 6480464 | Ethanol results in increased activity of SREBF1 protein | CTD | PMID:18620774 |
| ethanol | multiple interactions | ISO | RGD:69423 | 6480464 | Ethanol results in increased acetylation of and results in increased activity of SREBF1 protein; more ... | CTD | PMID:18239056 |
| ezetimibe | decreases expression | ISO | RGD:69473 | 6480464 | ezetimibe results in decreased expression of SREBF1 mRNA | CTD | PMID:16177187 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:19593819 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 protein | CTD | PMID:15066988 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 more ... |
| fructose | affects localization | EXP | | 6480464 | Fructose affects the localization of SREBF1 protein alternative form | CTD | PMID:22698815 |
| fructose | multiple interactions | EXP | | 6480464 | Phenylbutyrates inhibits the reaction [Fructose results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:22698815 |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:11934685 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:15123654 more ... |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:19196556 more ... |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:18346472 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:15066988 more ... |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:19196556 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 more ... |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:18346472 more ... |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 more ... |
| fructose | multiple interactions | ISO | RGD:69423 | 6480464 | Tea inhibits the reaction [Fructose results in increased expression of SREBF1 mRNA] | CTD | PMID:19193814 |
| fructose | multiple interactions | ISO | RGD:69423 | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of SREBF1 mRNA] | CTD | PMID:19196556 |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:11934685 more ... |
| fructose | increases expression | ISO | RGD:69423 | 6480464 | Fructose results in increased expression of SREBF1 protein | CTD | PMID:19799862 |
| fructose | multiple interactions | ISO | RGD:69423 | 6480464 | Fructose promotes the reaction [RBMX protein binds to SREBF1 promoter] | CTD | PMID:17188681 |
| fructose | multiple interactions | ISO | RGD:69423 | 6480464 | atorvastatin inhibits the reaction [Fructose results in increased activity of SREBF1 protein]; more ... | CTD | PMID:19053045 |
| fructose | affects response to substance | EXP | | 6480464 | SREBF1 promoter SNP affects the susceptibility to Fructose | CTD | PMID:15123654 |
| fructose | multiple interactions | EXP | | 6480464 | SCD1 affects the reaction [Fructose results in increased expression of SREBF1 protein]; more ... | CTD | PMID:15066988 |
| fructose | increases expression | EXP | | 6480464 | Fructose results in increased expression of SREBF1 mRNA | CTD | PMID:15066988 more ... |
| fumonisin B1 | decreases expression | EXP | | 6480464 | fumonisin B1 results in decreased expression of SREBF1 mRNA | CTD | PMID:16221962 |
| galactose | increases expression | EXP | | 6480464 | Galactose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 |
| gamma-hexachlorocyclohexane | decreases expression | ISO | RGD:69423 | 6480464 | Lindane results in decreased expression of SREBF1 mRNA | CTD | PMID:17785943 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 mRNA | CTD | PMID:15066988 PMID:10913129 |
| glucose | multiple interactions | ISO | RGD:69473 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]]; more ... | CTD | PMID:23319015 |
| glucose | increases expression | ISO | RGD:69473 | 6480464 | Glucose results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:23319015 |
| glucose | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein] | CTD | PMID:23090186 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 protein | CTD | PMID:23090186 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of SREBF1 mRNA | CTD | PMID:10913129 PMID:15066988 |
| heptadecafluorononanoic acid | increases expression | ISO | RGD:69423 | 6480464 | perfluoro-n-nonanoic acid results in increased expression of SREBF1 mRNA | CTD | PMID:22648072 |
| imipramine | multiple interactions | ISO | RGD:69473 | 6480464 | Imipramine results in increased cleavage of and results in increased activity of SREBF1 protein | CTD | PMID:16324787 |
| indole-3-methanol | affects expression | ISO | RGD:69423 | 6480464 | indole-3-carbinol affects the expression of SREBF1 mRNA | CTD | PMID:21396975 |
| ketamine | increases expression | ISO | RGD:69423 | 6480464 | Ketamine results in increased expression of SREBF1 mRNA | CTD | PMID:20080153 |
| L-methionine | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:19593819 |
| lithocholic acid | multiple interactions | EXP | | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of SREBF1 mRNA] | CTD | PMID:20359477 |
| lithocholic acid | decreases expression | EXP | | 6480464 | Lithocholic Acid results in decreased expression of SREBF1 mRNA | CTD | PMID:20359477 |
| losartan | multiple interactions | ISO | RGD:69423 | 6480464 | Losartan inhibits the reaction [AGT protein results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:19109942 |
| LY294002 | multiple interactions | ISO | RGD:69473 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [FGF7 protein results in increased expression of SREBF1 protein] | CTD | PMID:16162944 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [Lipopolysaccharides affects the localization of SREBF1 protein] | CTD | PMID:21689150 |
| microcystin-LR | decreases expression | EXP | | 6480464 | cyanoginosin LR results in decreased expression of SREBF1 mRNA | CTD | PMID:17654400 |
| mirtazapine | multiple interactions | ISO | RGD:69473 | 6480464 | mirtazapine results in increased cleavage of and results in increased activity of SREBF1 protein | CTD | PMID:16324787 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:69473 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of SREBF1 mRNA | CTD | PMID:23118965 |
| N-methylformamide | decreases expression | EXP | | 6480464 | methylformamide results in decreased expression of SREBF1 mRNA; more ... | CTD | PMID:17040096 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:69473 | 6480464 | Diethylnitrosamine results in decreased expression of SREBF1 mRNA | CTD | PMID:21527772 |
| naloxone | decreases expression | ISO | RGD:69423 | 6480464 | Naloxone results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 |
| nevirapine | increases expression | ISO | RGD:69473 | 6480464 | Nevirapine results in increased expression of SREBF1 mRNA | CTD | PMID:21619898 |
| nicotinamide | multiple interactions | ISO | RGD:69473 | 6480464 | Niacinamide inhibits the reaction [platycodin D inhibits the reaction [Glucose results in increased expression of SREBF1 protein]] | CTD | PMID:23319015 |
| olanzapine | multiple interactions | EXP | | 6480464 | olanzapine promotes the reaction [SREBF1 protein results in increased expression of LDLR mRNA]; more ... | CTD | PMID:17651982 |
| olanzapine | increases expression | EXP | | 6480464 | olanzapine results in increased expression of SREBF1 mRNA | CTD | PMID:17651982 |
| oleic acid | decreases expression | ISO | RGD:69473 | 6480464 | Oleic Acid results in decreased expression of SREBF1 mRNA | CTD | PMID:15949695 |
| olmesartan | decreases expression | ISO | RGD:69423 | 6480464 | olmesartan medoxomil results in decreased expression of SREBF1 mRNA | CTD | PMID:18501344 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of SREBF1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | decreases expression | ISO | RGD:69423 | 6480464 | Acetaminophen results in decreased expression of SREBF1 mRNA | CTD | PMID:17202758 more ... |
| paracetamol | decreases expression | ISO | RGD:69423 | 6480464 | Acetaminophen results in decreased expression of SREBF1 mRNA | CTD | PMID:17202762 more ... |
| paracetamol | decreases expression | ISO | RGD:69423 | 6480464 | Acetaminophen results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 more ... |
| paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SREBF1 mRNA | CTD | PMID:17562736 |
| paracetamol | decreases expression | ISO | RGD:69423 | 6480464 | Acetaminophen results in decreased expression of SREBF1 mRNA | CTD | PMID:17202758 more ... |
| paracetamol | decreases expression | ISO | RGD:69423 | 6480464 | Acetaminophen results in decreased expression of SREBF1 mRNA | CTD | PMID:17202762 more ... |
| perfluorooctane-1-sulfonic acid | decreases expression | ISO | RGD:69423 | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SREBF1 mRNA | CTD | PMID:19162173 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69423 | 6480464 | perfluorooctane sulfonic acid results in increased expression of SREBF1 mRNA | CTD | PMID:21723365 PMID:18692542 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69423 | 6480464 | perfluorooctane sulfonic acid results in increased expression of SREBF1 mRNA | CTD | PMID:18692542 PMID:21723365 |
| perfluorooctane-1-sulfonic acid | increases expression | ISO | RGD:69423 | 6480464 | perfluorooctane sulfonic acid results in increased expression of SREBF1 mRNA | CTD | PMID:18692542 |
| perfluorooctanoic acid | increases expression | ISO | RGD:69473 | 6480464 | perfluorooctanoic acid results in increased expression of SREBF1 mRNA | CTD | PMID:21723365 |
| perfluorooctanoic acid | increases expression | ISO | RGD:69423 | 6480464 | perfluorooctanoic acid results in increased expression of SREBF1 mRNA | CTD | PMID:21723365 |
| phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of SREBF1 mRNA] | CTD | PMID:19482888 |
| phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of SREBF1 mRNA | CTD | PMID:23091169 |
| phenobarbital | decreases expression | ISO | RGD:69423 | 6480464 | Phenobarbital results in decreased expression of SREBF1 mRNA | CTD | PMID:19162173 |
| phenobarbital | decreases expression | EXP | | 6480464 | Phenobarbital results in decreased expression of SREBF1 mRNA | CTD | PMID:19482888 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SREBF1 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SREBF1 mRNA | CTD | PMID:18301758 PMID:17426115 |
| pirinixic acid | increases expression | ISO | RGD:69423 | 6480464 | pirinixic acid results in increased expression of SREBF1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | multiple interactions | ISO | RGD:69423 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased localization of and results in decreased activity of SREBF1 protein; more ... | CTD | PMID:19248225 |
| pirinixic acid | increases cleavage | EXP | | 6480464 | pirinixic acid results in increased cleavage of SREBF1 protein | CTD | PMID:15777286 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein affects the reaction [pirinixic acid results in increased cleavage of SREBF1 protein] | CTD | PMID:15777286 |
| pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of SREBF1 mRNA | CTD | PMID:17426115 PMID:18301758 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [[Methionine deficiency co-treated with Choline deficiency] results in increased expression of SREBF1 mRNA] | CTD | PMID:19593819 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | pirinixic acid inhibits the reaction [Ethanol results in increased expression of SREBF1 mRNA] | CTD | PMID:18620774 |
| pregnenolone 16alpha-carbonitrile | decreases expression | ISO | RGD:69423 | 6480464 | Pregnenolone Carbonitrile results in decreased expression of SREBF1 mRNA | CTD | PMID:19162173 |
| pregnenolone 16alpha-carbonitrile | multiple interactions | EXP | | 6480464 | Pregnenolone Carbonitrile inhibits the reaction [Lithocholic Acid results in decreased expression of SREBF1 mRNA] | CTD | PMID:20359477 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of SREBF1 mRNA | CTD | PMID:21278054 |
| quercetin | increases expression | ISO | RGD:69473 | 6480464 | Quercetin results in increased expression of SREBF1 mRNA | CTD | PMID:21632981 |
| raloxifene | multiple interactions | ISO | RGD:69473 | 6480464 | [Raloxifene co-treated with ESR2 protein] results in decreased expression of SREBF1 mRNA | CTD | PMID:19059307 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SREBF1 mRNA; more ... | CTD | PMID:22659145 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SREBF1 protein | CTD | PMID:23090186 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein] | CTD | PMID:23090186 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] | CTD | PMID:18755807 |
| resveratrol | increases expression | ISO | RGD:69473 | 6480464 | resveratrol results in increased expression of SREBF1 protein modified form | CTD | PMID:22153697 |
| resveratrol | multiple interactions | ISO | RGD:69473 | 6480464 | [resveratrol results in increased activity of and results in increased cleavage of [SREBF1 protein co-treated with SREBF2 protein]] which results in increased expression of LDLR mRNA; more ... | CTD | PMID:22153697 |
| resveratrol | multiple interactions | ISO | RGD:69423 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased acetylation of and results in increased activity of SREBF1 protein] | CTD | PMID:18239056 |
| risperidone | multiple interactions | EXP | | 6480464 | Berberine inhibits the reaction [Risperidone results in increased expression of SREBF1 mRNA]; more ... | CTD | PMID:20564506 |
| risperidone | increases expression | EXP | | 6480464 | Risperidone results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:20564506 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | [Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of SREBF1 mRNA; more ... | CTD | PMID:16054899 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of SREBF1 mRNA | CTD | PMID:18534569 PMID:23322813 |
| rosiglitazone | increases expression | ISO | RGD:69423 | 6480464 | rosiglitazone results in increased expression of SREBF1 protein | CTD | PMID:22726273 |
| rosiglitazone | increases expression | EXP | | 6480464 | rosiglitazone results in increased expression of SREBF1 mRNA | CTD | PMID:18534569 |
| rosiglitazone | decreases expression | ISO | RGD:69423 | 6480464 | rosiglitazone results in decreased expression of SREBF1 mRNA | CTD | PMID:21515302 |
| rosiglitazone | increases expression | ISO | RGD:69423 | 6480464 | rosiglitazone results in increased expression of SREBF1 mRNA | CTD | PMID:19201733 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | rosiglitazone inhibits the reaction [Ethanol results in decreased expression of SREBF1 mRNA] | CTD | PMID:22173916 |
| rosiglitazone | multiple interactions | ISO | RGD:69423 | 6480464 | rosiglitazone inhibits the reaction [Fructose results in increased expression of SREBF1 mRNA] | CTD | PMID:19196556 |
| rosiglitazone | increases expression | ISO | RGD:69473 | 6480464 | rosiglitazone results in increased expression of SREBF1 mRNA | CTD | PMID:16806087 |
| rotenone | increases expression | ISO | RGD:69473 | 6480464 | Rotenone results in increased expression of SREBF1 mRNA | CTD | PMID:17651460 |
| rotenone | decreases expression | ISO | RGD:69423 | 6480464 | Rotenone results in decreased expression of SREBF1 mRNA | CTD | PMID:19693701 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | decreases expression | ISO | RGD:69423 | 6480464 | Buthionine Sulfoximine results in decreased expression of SREBF1 mRNA | CTD | PMID:20482862 |
| selenium atom | increases expression | ISO | RGD:69423 | 6480464 | Selenium results in increased expression of SREBF1 mRNA | CTD | PMID:19022953 |
| simvastatin | increases localization | ISO | RGD:69473 | 6480464 | Simvastatin results in increased localization of SREBF1 protein | CTD | PMID:17655842 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of SREBF1 mRNA | CTD | PMID:15358118 |
| sodium dichromate | affects expression | ISO | RGD:69423 | 6480464 | sodium bichromate affects the expression of SREBF1 mRNA | CTD | PMID:22110744 |
| stavudine | multiple interactions | ISO | RGD:69423 | 6480464 | Carnitine inhibits the reaction [Stavudine results in increased expression of SREBF1 mRNA] | CTD | PMID:18299183 |
| stavudine | increases expression | ISO | RGD:69423 | 6480464 | Stavudine results in increased expression of SREBF1 mRNA | CTD | PMID:18299183 |
| tamoxifen | multiple interactions | ISO | RGD:69473 | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of SREBF1 mRNA | CTD | PMID:19059307 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of SREBF1 mRNA | CTD | PMID:16579987 |
| tetrachloromethane | decreases expression | ISO | RGD:69423 | 6480464 | Carbon Tetrachloride results in decreased expression of SREBF1 mRNA | CTD | PMID:17202758 PMID:17522070 |
| tetrachloromethane | decreases expression | ISO | RGD:69423 | 6480464 | Carbon Tetrachloride results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 PMID:17202758 |
| tetracycline | increases expression | EXP | | 6480464 | Tetracycline results in increased expression of SREBF1 mRNA | CTD | PMID:16917069 |
| tetracycline | decreases expression | ISO | RGD:69423 | 6480464 | Tetracycline results in decreased expression of SREBF1 mRNA | CTD | PMID:17202758 PMID:17522070 |
| tetracycline | decreases expression | ISO | RGD:69423 | 6480464 | Tetracycline results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 PMID:17202758 |
| theophylline | decreases expression | ISO | RGD:69423 | 6480464 | Theophylline results in decreased expression of SREBF1 mRNA | CTD | PMID:17522070 |
| topiramate | increases expression | ISO | RGD:69423 | 6480464 | topiramate results in increased expression of SREBF1 mRNA | CTD | PMID:16979414 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SREBF1 mRNA; more ... | CTD | PMID:22659145 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of SREBF1 protein | CTD | PMID:23090186 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in increased expression of SREBF1 protein] | CTD | PMID:23090186 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased expression of SREBF1 protein] | CTD | PMID:18755807 |
| trans-resveratrol | increases expression | ISO | RGD:69473 | 6480464 | resveratrol results in increased expression of SREBF1 protein modified form | CTD | PMID:22153697 |
| trans-resveratrol | multiple interactions | ISO | RGD:69473 | 6480464 | [resveratrol results in increased activity of and results in increased cleavage of [SREBF1 protein co-treated with SREBF2 protein]] which results in increased expression of LDLR mRNA; more ... | CTD | PMID:22153697 |
| trans-resveratrol | multiple interactions | ISO | RGD:69423 | 6480464 | resveratrol inhibits the reaction [Ethanol results in increased acetylation of and results in increased activity of SREBF1 protein] | CTD | PMID:18239056 |
| tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of SREBF1 mRNA | CTD | PMID:23322813 |
| triolein | multiple interactions | EXP | | 6480464 | Triolein inhibits the reaction [SCD1 gene mutant form inhibits the reaction [Fructose results in increased expression of SREBF1 mRNA]]; more ... | CTD | PMID:15066988 |
| troglitazone | multiple interactions | ISO | RGD:69423 | 6480464 | [[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides | CTD | PMID:19248225 |
| troglitazone | decreases expression | ISO | RGD:69423 | 6480464 | troglitazone results in decreased expression of SREBF1 mRNA | CTD | PMID:10900012 |
| troglitazone | decreases expression | ISO | RGD:69473 | 6480464 | troglitazone results in decreased expression of SREBF1 mRNA | CTD | PMID:19140230 |
| tunicamycin | increases cleavage | EXP | | 6480464 | Tunicamycin results in increased cleavage of SREBF1 protein | CTD | PMID:22414386 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SREBF1 mRNA | CTD | PMID:17963808 PMID:17292431 |
| valproic acid | affects expression | EXP | | 6480464 | Valproic Acid affects the expression of SREBF1 mRNA | CTD | PMID:17292431 PMID:17963808 |